insights_auto
Why is KNSA down 2,18%?
Dive Deeperchevron_right
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
US$94,23
arrow_downward
-2,18%(-2,10) 1D
US$94,23
0,00% (0,00)
bedtimeAfter hours
Closed: 16 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KNSA...
Open
US$96,67
High
US$97,96
Low
US$93,65
Mkt. cap
7,40 ຕື້
Avg. vol.
822,12 ພັນ
Volume
455,21 ພັນ
P/E ratio
71,92
52-wk high
US$99,31
52-wk low
US$37,02
EPS
US$1,31
Beta
0,07
Shares outstanding
48,84 ລ້ານ
No. of employees
366
Open
US$96,67
High
US$97,96
Low
US$93,65
Mkt. cap
7,40 ຕື້
Avg. vol.
822,12 ພັນ
Volume
455,21 ພັນ
P/E ratio
71,92
52-wk high
US$99,31
52-wk low
US$37,02
EPS
US$1,31
Beta
0,07
Shares outstanding
48,84 ລ້ານ
No. of employees
366
News stories
From web sources and news partners
TradingView
·
11 ຊົ່ວໂມງກ່ອນ
KNSA: ARCALYST growth and a H2 2027 KPL-387 readout anchor the outlook
Investing.com
·
11 ຊົ່ວໂມງກ່ອນ
Kiniksa at Jefferies Global Healthcare Conference: arcalyst growth rolls on
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
Headquartersລອນດອນ, ປະເທດອັງກິດ, ສະຫະລາດຊະອະນາຈັກ
SectorHealth Care
IndustryBiotechnology
Websitekiniksa.com